Table 2 Angiographic and procedural characteristics according to COPD diagnosis
Variables | COPD (n = 810) | Non COPD (n = 14,876) | P-value |
|---|---|---|---|
Radial access (%) | 648 (80.0) | 1456 (77.0) | 0.048 |
Culprit vessel | 0.009 | ||
Left main—n (%) | 17 (2.1) | 224 (1.5) | |
LAD—n (%) | 328 (40.5) | 6872 (46.2) | |
Circumflex—n (%) | 151 (18.6) | 2134 (14.3) | |
RCA—n (%) | 308 (38.0) | 5532 (37.2) | |
Anterolateral branch—n (%) | 2 (0.2) | 39 (0.3) | |
SVG—n (%) | 4 (0.5) | 75 (0.5) | |
In-stent thrombosis—n (%) | 48 (5.9) | 560 (3.8) | 0.002 |
Multivessel disease—n (%) | 426 (52.6) | 7371 (49.5) | 0.239 |
Preprocedural TIMI 0 flow—n (%) | 513 (63.3) | 9967 (67.0) | 0.031 |
Thrombectomy—n (%) | 151 (18.6) | 2412 (16.2) | 0.069 |
Stenting—n (%) | 753 (93.0) | 13,647 (91.7) | 0.456 |
Drug-eluting stent—n (%) | 730 (90.1) | 13,163 (88.5) | 0.153 |
Postprocedural TIMI 3 flow—n (%) | 745 (92.0) | 13,692 (92.0) | 0.954 |
Gp IIb–IIIa inhibitors/Cangrelor—n (%) | 189 (23.3) | 3050 (20.5) | 0.053 |
Bivalirudin—n (%) | 2 (0.2) | 33 (0.2) | 0.883 |
Mechanical support—n (%) | 32 (4.0) | 459 (3.1) | 0.169 |
Additional PCI | 0.584 | ||
During the index procedure—n (%) | 75 (9.3) | 1305 (8.8) | |
Staged—n (%) | 94 (11.6) | 1583 (10.6) | |
DAPT therapy—n (%) | 795 (98.1) | 14,717 (98.9) | 0.038 |